Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -61.60M
March 31, 2026 18.99M
December 31, 2025 -30.30M
September 30, 2025 -34.69M
June 30, 2025 -41.02M
March 31, 2025 -42.87M
December 31, 2024 3.996M
September 30, 2024 -12.22M
June 30, 2024 -28.48M
March 31, 2024 -62.35M
December 31, 2023 -76.55M
September 30, 2023 -18.80M
June 30, 2023 -27.14M
Date Value
March 31, 2023 -64.53M
December 31, 2022 -58.27M
September 30, 2022 -1.033M
June 30, 2022 -75.89M
March 31, 2022 -28.28M
December 31, 2021 -52.36M
September 30, 2021 -24.44M
June 30, 2021 -39.79M
March 31, 2021 -44.99M
December 31, 2020 -13.90M
September 30, 2020 -4.91M
June 30, 2020 -10.24M
March 31, 2020 -26.50M

Free Cash Flow Definition

Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Astrana Health, Inc. 28.87M
Starling Oncology, Inc. 11.03M
Nakamoto, Inc. -6.559M
American Oncology Network, Inc. --
Biodesix, Inc. -1.855M